Literature DB >> 7639626

Correlations between triplet repeat expansion and clinical features in Huntington's disease.

S Claes1, K Van Zand, E Legius, R Dom, M Malfroid, F Baro, J Godderis, J J Cassiman.   

Abstract

OBJECTIVE: To investigate possible correlations between the length of the (CAG)n trinucleotide repeat in Hungtington's disease gene IT15 and clinical features (age at onset, symptoms at onset, and mode of progression) in Huntington's disease.
DESIGN: In 59 patients with Huntington's disease, the expansion of the (CAG)n trinucleotide repeat was determined and clinical data were obtained retrospectively.
SETTING: The Center for Human Genetics, affiliated with a university hospital. PATIENTS: All patients belonged to an initial group of 248 individuals tested in an indirect predictive testing procedure.
RESULTS: A good correlation was found between the expansion of the (CAG)n trinucleotide repeat and the age at onset (r = -.71). No correlation was found between the repeat length of the normal allele and the age at onset. No correlations were found between repeat expansion and other clinical features, such as the nature of the symptoms at onset (neurologic, psychiatric/cognitive, or both) and the mode of progression.
CONCLUSION: Factors that determine the nature of symptoms at onset and the mode of progression of Huntington's disease seem to be operating independently of the (CAG)n trinucleotide repeat in gene IT15.

Entities:  

Mesh:

Year:  1995        PMID: 7639626     DOI: 10.1001/archneur.1995.00540320021009

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  17 in total

Review 1.  Evidence from biomarkers and surrogate endpoints.

Authors:  Andrew Feigin
Journal:  NeuroRx       Date:  2004-07

2.  Clinical rationale of genetic testing in dementia.

Authors:  G B Frisoni; M Trabucchi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-03       Impact factor: 10.154

Review 3.  The genetic defect causing Huntington's disease: repeated in other contexts?

Authors:  J F Gusella; F Persichetti; M E MacDonald
Journal:  Mol Med       Date:  1997-04       Impact factor: 6.354

Review 4.  Anticipation and CAG*CTG repeat expansion in schizophrenia and bipolar affective disorder.

Authors:  M Teresa Fortune; James L Kennedy; John B Vincent
Journal:  Curr Psychiatry Rep       Date:  2003-06       Impact factor: 5.285

5.  Managing juvenile Huntington's disease.

Authors:  Oliver W J Quarrell; Martha A Nance; Peggy Nopoulos; Jane S Paulsen; Jonathan A Smith; Ferdinando Squitieri
Journal:  Neurodegener Dis Manag       Date:  2013-06-01

6.  The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size.

Authors:  R R Brinkman; M M Mezei; J Theilmann; E Almqvist; M R Hayden
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

Review 7.  Huntington's Disease: Relationship Between Phenotype and Genotype.

Authors:  Yi-Min Sun; Yan-Bin Zhang; Zhi-Ying Wu
Journal:  Mol Neurobiol       Date:  2016-01-07       Impact factor: 5.590

8.  Genetic polymorphisms adjacent to the CAG repeat influence clinical features at onset in Huntington's disease.

Authors:  I Vuillaume; P Vermersch; A Destée; H Petit; B Sablonnière
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-06       Impact factor: 10.154

9.  Multivariate clustering of progression profiles reveals different depression patterns in prodromal Huntington disease.

Authors:  Ji-in Kim; Jeffrey D Long; James A Mills; Elizabeth McCusker; Jane S Paulsen
Journal:  Neuropsychology       Date:  2015-05-25       Impact factor: 3.295

10.  Current Pharmacological Management in Juvenile Huntington's Disease.

Authors:  Lisa Robertson; Helen Santini; Kirsty L O'Donovan; Ferdinando Squitieri; Roger A Barker; Maria Rakowicz; G Bernhard Landwehrmeyer; Oliver Quarrell
Journal:  PLoS Curr       Date:  2012-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.